HK Stock Market Move | Genscript Biotech (01548) opens over 4% higher; company clarifies trading counter rumors, group business and operations remain normal.
Genscript Biotech (01548) opened over 4% higher. As of press time, it is up 4.24% at HK$31.5, with a turnover of HK$12.7358 million.
Genscript Biotech (01548) opened over 4% higher. As of press time, it is up 4.24% at HK$31.5, with turnover of HK$12.7358 million.
On the news front, Genscript Biotech issued a clarification announcement stating that a certain financial media outlet had excerpted information from a previous announcement and spread a message claiming that the company would close its trading counter, which may cause investors to misunderstand. The temporary counter will be closed at 4:10 p.m. on November 4, 2026, which is part of the existing timetable for the arrangement to change the board lot size from 2,000 shares to 1,000 shares.
The company stated that it held its 2026 annual investor open day on October 30, 2026, and that the group's business and operations remain normal, with no material changes in business management or financial condition. After reasonable inquiry, the board confirmed that as of the date of this announcement, it is not aware of any reason for the fluctuation in the share price, nor of any inside information required to be disclosed under Part XIVA of the Securities and Futures Ordinance.
Related Articles

Goldman Sachs: Raises Hong Kong's 2026 GDP growth forecast to 5%, 2027 forecast up to 3.1%
HK Stock Market Move | CSTONE PHARMA-B (02616) rises nearly 4% on clinical development collaboration with Kimia to jointly advance a drug with first-in-class potential.

HK Stock Market Move | ACTIVATION GP (09919) rises over 5%; interim profit attributable to shareholders RMB22.879 million; cumulative repurchase of 1.38 million shares during the year.
Goldman Sachs: Raises Hong Kong's 2026 GDP growth forecast to 5%, 2027 forecast up to 3.1%

HK Stock Market Move | CSTONE PHARMA-B (02616) rises nearly 4% on clinical development collaboration with Kimia to jointly advance a drug with first-in-class potential.
HK Stock Market Move | ACTIVATION GP (09919) rises over 5%; interim profit attributable to shareholders RMB22.879 million; cumulative repurchase of 1.38 million shares during the year.






